Archives
-
Recombinant Human EGF in Mechanistic Screens
2026-08-18
Epidermal Growth Factor and recombinant human EGF can do more than stimulate growth: they can define the signaling context of mechanistic cancer assays. This guide connects APExBIO P1008 specifications with the EphA2–MYC synthetic-lethality study while emphasizing controls, interpretation, and translational limits.
-
Cyclosporin A Workflows for Mitophagy Research
2026-08-17
Cyclosporin A connects cyclophilin inhibition with practical studies of mitophagy, pyroptosis, immune signaling, and mitochondrial injury. This guide translates a recent chondrocyte study into controlled assays, handling decisions, and troubleshooting strategies without treating one pharmacologic tool as a universal mechanism proof.
-
Otilonium Bromide for Reproducible Cell Assays
2026-08-17
This scenario-based guide explains how Otilonium Bromide, SKU B1607, can be integrated into cell viability, proliferation, and cholinergic-signaling experiments without confusing receptor modulation with direct cytotoxicity. It covers formulation choice, vehicle controls, protocol parameters, interpretation, and practical vendor-selection criteria.
-
ZCL278 and the Next Wave of Cdc42 Translation
2026-08-16
ZCL278 is a selective Cdc42 inhibitor that connects molecular perturbation with measurable changes in cell motility, neuronal dynamics, and disease-relevant signaling. This thought-leadership guide places ZCL278 alongside emerging evidence that Cdc42 regulates a PKCζ/GSK-3β/β-catenin axis in kidney fibrosis, while defining the controls and model boundaries needed for credible translation.
-
(S)-(+)-Ibuprofen: COX-to-Ecosystem Insight
2026-08-15
Explore how (S)-(+)-Ibuprofen functions as a COX inhibitor across cellular, translational, and aquatic research. This evidence-based guide connects stereochemistry, prostaglandin suppression, assay design, and environmental interpretation.
-
Mecamylamine Hydrochloride in Gut–Brain Assays
2026-08-14
Mecamylamine hydrochloride provides a pharmacological way to interrogate nicotinic signaling in gut–brain and neuropsychiatric models. This article translates recent Bacteroides fragilis seizure findings into practical assay decisions while distinguishing receptor-level evidence from therapeutic claims.
-
PKH26 Red Fluorescent Cell Linker Kit Guide
2026-08-14
The PKH26 Red Fluorescent Cell Linker Kit provides stable red labeling of live-cell membrane lipid regions for tracing and proliferation-oriented assays. It is intended for cell membrane labeling in vitro or in vivo, not for intracellular, soluble, or other non-membrane targets.
-
Fluconazole in Candida Biofilm Assay Design
2026-08-13
Fluconazole is more than an antifungal readout: it can function as a mechanistic perturbation for dissecting Candida albicans biofilm tolerance. This guide connects fluconazole exposure design with PP2A-regulated autophagy, antifungal susceptibility testing, and translational infection-model decisions.
-
Camptothecin: A Stress-Test for Genome Plasticity
2026-08-13
Camptothecin is a topoisomerase I inhibitor that converts DNA-repair biology into a measurable experimental stress. This article connects its damage and autophagy readouts with new evidence that prion-based protein assemblies can reversibly tune mutagenesis, offering a framework for more informative cancer and genome-stability assays.
-
LSE mRNA Delivery for Durable T Cell Immunity
2026-08-12
Zhou and colleagues engineered a lipid nanoparticle-stabilized emulsion (LSE) that redirects mRNA expression toward antigen-presenting cells and coordinates delivery, antigen presentation, and immune activation. In mice, this spatially controlled approach generated durable T cell responses, broader T cell repertoires, and activity in antiviral and tumor models, while also revealing important translational limitations.
-
Astrocytic GAT-3 in Dentate Gyrus Memory
2026-08-12
The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission rather than a passive GABA-clearance mechanism. Its combined electrophysiological, optogenetic, imaging, histological, and behavioral evidence links GAT-3-dependent astrocytic Ca2+ signaling to presynaptic GluN2B-containing NMDA receptor activity and contextual fear memory formation.
-
DHC Microarray Patch for Diabetic Wound Repair
2026-08-11
This study developed a GelMA microneedle platform containing dihydrocapsaicin-loaded cerium metal–organic frameworks for sustained treatment of diabetic wounds. The reported system addressed oxidative stress, macrophage dysregulation, and impaired angiogenesis in a coordinated manner, offering a material-based strategy for whole-course wound management.
-
Dabigatran Etexilate: Oral Thrombin Inhibition
2026-08-11
The reference paper presents dabigatran etexilate as the first marketed oral direct thrombin inhibitor in the United States and synthesizes its pharmacology, pharmacokinetics, clinical efficacy, safety, and therapeutic positioning. Its main practical implication is that predictable oral anticoagulation can address several limitations of vitamin K antagonists and parenteral agents, while renal function and bleeding risk remain essential constraints.
-
4-MUG: A Quantitative Window into Lysosomal GCase
2026-08-10
4-Methylumbelliferyl-β-D-Glucopyranoside (4-MUG) converts β-glucosidase and β-glucocerebrosidase activity into a sensitive fluorescent signal. This guide explains how to use that signal as a carefully controlled functional endpoint in Gaucher disease, lysosomal biology, and emerging GBA1-mRNA studies.
-
Mecamylamine Hydrochloride in Gut-Brain Assays
2026-08-09
Mecamylamine hydrochloride provides a BBB-permeable, non-competitive way to test whether nicotinic signaling is necessary in neuronal, vagal, and neuropsychiatric models. This workflow-focused guide connects receptor pharmacology with the gut-brain findings reported for Bacteroides fragilis while emphasizing controls, formulation, and interpretation limits.
543 records 7/37 page Previous Next First page 上5页 678910 下5页 Last page